On May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation.
Weekly Trust on MSN
Malaria Day: Rising treatment cost, prevalence deepen Nigerians' burden
As the world marks World Malaria Day 2026 today, residents across several states have decried the rising cost of malaria treatment and the prevalence of the disease, describing it as a deepening ...
Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...
ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results